Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
NASDAQ:CBLL
CBLL Stock Chart & Stats
$11.40
-$0.15(-0.64%)
At close: 4:00 PM EST
$11.40
-$0.15(-0.64%)
Day’s Range― - ―
52-Week Range$10.01 - $32.75
Previous CloseN/A
Volume46.56K
Average Volume (3M)251.22K
Market Cap
$417.97M
Enterprise Value$523.90M
Total Cash (Recent Filing)$177.43M
Total Debt (Recent Filing)$21.55M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Nov 18, 2025EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding36,663,967
10 Day Avg. Volume320,210
30 Day Avg. Volume251,217
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue6.77
Enterprise Value/Gross Profit7.71
Enterprise Value/Ebitda-11.35
Forecast
1Y Price Target
$26.25Price Target Upside130.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Market PositionCBLL continues to have the strongest clinical data and AI moat, both of which come from first mover advantage.
Revenue GrowthCeribell raised its FY25 revenue guidance to $85M-$88M, reflecting more than just the Q2 beat but also the anticipated continued momentum.
Supply Chain StrategyCBLL has further de-risked its supply chain by establishing a production line in Vietnam, creating supply redundancy and allowing the company to potentially benefit from more favorable trade policies.
Bears Say
Operating ExpensesOpex totaled $33.6M, reflecting an increase of 56% from last year, primarily attributable to investments in the commercial team, increased headcount, legal expenses and expenses tied to being a public company.
Stock PerformanceCBLL shares remain down roughly 50% year to date and well off their highs seen last December despite consistently exceeding Street expectations.
Ceribell, Inc. News
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $10.01 and its highest was $32.75 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $417.97M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 15 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on Aug 05, 2025. The company reported -$0.38 earnings per share for the quarter, beating the consensus estimate of -$0.397 by $0.017.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate is -0.41.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 36,663,967 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.38 in its last earnings report, beating expectations of -$0.397. Following the earnings report the stock price went down -15.252%.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
Ceribell, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.25 (130.26% Upside)
$26.25 (130.26% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $92.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Company Description
Ceribell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
CBLL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and positive feedback for new product initiatives, alongside increased costs related to expansion and legal challenges. Despite the increased net loss, the raised revenue guidance and strong market reception for new indications suggest a positive outlook.View all CBLL earnings summariesCBLL Stock 12 Month Forecast
Average Price Target
$26.25
▲(130.26% Upside)
Technical Analysis
Ownership Overview
16.85% Insiders
22.13% Mutual Funds
34.27% Other Institutional Investors
19.83% Public Companies and
Individual Investors